🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Canada / NCT07293312
Starting soon Not applicable

Optimizing the Use of Virtual Reality in Rehabilitation for Individuals With Persistent Shoulder Pain

NCT07293312 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2026-01-15
Last updated
2025-12-19

Condition(s) studied

Rotator Cuff Related Shoulder Pain

Investigational drug(s) / intervention(s)

Virtual reality unimanual distraction taskVirtual reality bimanual distraction taskVirtual reality unimanual reaching tasks with augmented visual feedbackVirtual reality unimanual reaching tasks with decreased visual feedback

Virtual reality unimanual distraction task: Unimanual tasks (performed with the affected limb) with unaltered visual feedback will involve distraction exercises in which participants move a tray toward targets while keeping a ball balanced on the tray. Three trials with varying levels of friction between the ball and tray will be presented to manipulate the task's difficulty.

Virtual reality bimanual distraction task: Bimanual tasks with unaltered visual feedback (targets positioned based on the affected limb) will involve distraction exercises in which participants move a tray toward targets while keeping a ball balanced on the tray. Three trials with varying levels of friction between the ball and tray will be presented to adjust task difficulty.

Virtual reality unimanual reaching tasks with augmented visual feedback: Three trials with varying levels of visual feedback alteration will be performed, corresponding to a 0%, 25%, or 50% amplification of movement in the virtual environment compared to the real world. While virtual targets will appear farther apart, the actual movement required to reach them will remain the same across all trials.

Virtual reality unimanual reaching tasks with decreased visual feedback: Three trials with varying levels of visual feedback alteration will be performed, corresponding to a 0%, 17%, or 33% reduction in movement in the virtual environment compared to the real world. Although the virtual targets will appear closer together, the actual movement required to reach them will remain the same across all trials.

Study summary

The primary objective of this clinical trial is to investigate the effect of a block of four specific virtual reality (VR) exercises on upper limb function, pain, kinesiophobia, and pain catastrophizing in individuals with rotator cuff-related shoulder pain (RCRSP). The secondary objective is to examine participants' tolerability of different VR interventions.

Study Procedures:

Participants will:

* Attend a face-to-face assessment to confirm eligibility and receive a standardized pain neurophysiology education session (week 0).
* Visit the clinic once weekly for four weeks to undergo the VR interventions and review pain education concepts (Weeks 5 to 8).
* Complete online questionnaires evaluating upper limb function, kinesiophobia, pain, sense of presence, and cybersickness.

Interventions

Four VR interventions will be tested:

* Unimanual distraction task with normal visual feedback
* Bimanual distraction task with normal visual feedback
* Unimanual reaching task with augmented visual feedback
* Unimanual reaching task with diminished visual feedback

Findings will guide clinicians in selecting the most effective VR interventions for shoulder impairment and assess the feasibility of implementing VR in a private physiotherapy clinic for individuals with RCRSP.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Rotator cuff-related shoulder pain (screen by phone and then confirmed by the physiotherapist at the initial evaluation: pain over the deltoid and/or upper arm region, pain associated with arm movement \[painful arc of movement\], and familiar pain reproduced with loading or resisted testing during external rotation of the arm) for at least 6 months * Minimum score of 15/100 on the shortened version of the Disabilities of the Arm, Shoulder, and Hand (1.5 times the minimally clinically important difference) Exclusion Criteria: * Unavailable for the 4 weeks intervention * Cannot understand or read French * Have a diagnosis of rheumatoid, inflammatory or neurodegenerative diseases * Have received a corticosteroid injection or any other type of injection (e.g., platelet-rich plasma, prolotherapy, hyaluronic acid) in the past three months for their current condition * Have bilateral shoulder pain * Have pain in another upper limb joint * Have signs of upper (e.g., bilateral paresthesia, hyperreflexia, or spasticity) or lower (e.g., decreased sensation or strength in dermatomes and myotomes, hypotonia, or hyporeflexia) motor neuron lesions * History of shoulder surgery, dislocation, or fracture * Presence of severe osteoarthritis, symptomatic acromioclavicular joint pathology, or adhesive capsulitis (defined as restriction of passive glenohumeral movement of at least 30% for two or more directions) * Full thickness rotator cuff tear, identified by imaging or clinical tests (lag signs and gross weakness)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Centre for Interdisciplinary Research in Rehabilitation and Social Integration Québec Quebec

More Laval University trials in Canada

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07293312 on ClinicalTrials.gov ↗ ← All trials in Canada